Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Cell Journal [Yakhteh]. 2017; 19 (1): 18-26
in English | IMEMR | ID: emr-185789

ABSTRACT

Objective: This study was designed to evaluate the effects of vitrification and in vitro culture of human ovarian tissue on the expression of oocytic and follicular cell-related genes


Materials and Methods: In this experimental study, ovarian tissue samples were obtained from eight transsexual women. Samples were cut into small fragments and were then assigned to vitrified and non-vitrified groups. In each group, some tissue fragments were divided into un-cultured and cultured [in alpha-MEM medium for 2 weeks] subgroups. The normality of follicles was assessed by morphological observation under a light microscope using hematoxylin and eosin [H and E] staining. Expression levels of factor in the germ line alpha [FIGLA], KIT ligand [KL], growth differentiation factor 9 [GDF-9] and follicle stimulating hormone receptor [FSHR] genes were quantified in both groups by real-time reverse transcriptase polymerase chain reaction [RT-PCR] at the beginning and the end of culture


Results: The percentage of normal follicles was similar between non-cultured vitrified and non-vitrified groups [P>0.05], however, cultured tissues had significantly fewer normal follicles than non-cultured tissues in both vitrified and non-vitrified groups [P<0.05]. In both cultured groups the rate of primary and secondary follicles was significantly higher than non-cultured tissues [P<0.05]. The expression of all examined genes was not significantly altered in both non-cultured groups. Whiles, in comparison with cultured tissues non-cultured tissues, the expression of FIGLA gene was significantly decreased, KL gene was not changed, GDF-9 and FSHR genes was significantly increased [P<0.05]


Conclusion: Human ovarian vitrification following in vitro culture has no impairing effects on follicle normality and development and expression of related-genes. However, in vitro culture condition has deleterious effects on normality of follicles


Subject(s)
Humans , Women , Young Adult , Adult , Gene Expression Regulation , Stem Cell Factor/genetics , Basic Helix-Loop-Helix Transcription Factors/genetics , Receptors, FSH/genetics , Fertility Preservation/methods , Tissue Culture Techniques
2.
Braz. j. med. biol. res ; 46(8): 700-707, ago. 2013. tab, graf
Article in English | LILACS | ID: lil-684532

ABSTRACT

Follicle cultures reproduce in vitro the functional features observed in vivo. In a search for an ideal model, we cultured bovine antral follicle wall sections (FWS) in a serum-free defined medium (DM) known to induce 17β-estradiol (E2) production, and in a nondefined medium (NDM) containing serum. Follicles were sectioned and cultured in NDM or DM for 24 or 48 h. Morphological features were determined by light microscopy. Gene expression of steroidogenic enzymes and follicle-stimulating hormone (FSH) receptor were determined by RT-PCR; progesterone (P4) and E2 concentrations in the media were measured by radioimmunoassay. DM, but not NDM, maintained an FWS morphology in vitro that was similar to fresh tissue. DM also induced an increase in the expression of all steroidogenic enzymes, except FSH receptor, but NDM did not. In both DM and NDM, there was a gradual increase in P4 throughout the culture period; however, P4 concentration was significantly higher in NDM. In both media, E2 concentration was increased at 24 h, followed by a decrease at 48 h. The E2:P4 ratio was higher in DM than in NDM. These results suggest that DM maintains morphological structure, upregulates the expression of steroidogenic enzyme genes, and maintains steroid production with a high E2:P4 ratio in FWS cultures.


Subject(s)
Animals , Cattle , Female , Culture Media/pharmacology , Estradiol/pharmacology , Ovarian Follicle/drug effects , Progesterone/pharmacology , Tissue Culture Techniques , Analysis of Variance , Aromatase/genetics , Culture Media, Serum-Free , Cholesterol Side-Chain Cleavage Enzyme/genetics , Gene Expression , Ovarian Follicle/anatomy & histology , Phosphoproteins/genetics , Progesterone Reductase/genetics , Reverse Transcriptase Polymerase Chain Reaction , Receptors, FSH/genetics , /genetics
3.
Genet. mol. res. (Online) ; 7(1): 243-251, Jan. 2008. ilus, tab, graf
Article in English | LILACS | ID: lil-553791

ABSTRACT

The purpose of the present research was to investigate the effects of polymorphisms of luteinizing hormone receptor (LHR) and follicle-stimulating hormone receptor (FSHR) genes, evaluated by polymerase chain reaction-restriction fragment length polymorphism in European-Zebu composite beef heifers from six different breed compositions. The polymorphism site analysis from digestion with HhaI and AluI restriction endonucleases allowed the genotype identification for LHR (TT, CT and CC) and FSHR (GG, CG and CC) genes. A high frequency of heterozygous animals was recorded in all breed compositions for both genes, except in two compositions for LHR. The probability of pregnancy (PP) at first breeding was used to evaluate the polymorphism effect on sexual precocity. The PP was analyzed as a binary trait, with a value of 1 (success) assigned to heifers that were diagnosed pregnant by rectal palpation and a value of 0 (failure) assigned to those that were not pregnant at that time. Heterozygous heifers showed a higher pregnancy rate (67 and 66% for LHR and FSHR genes, respectively), but no significant effects were observed for the genes studied (P = 0.9188 and 0.8831 for LHR and FSHR, respectively) on the PP. These results do not justify the inclusion of LHR and FSHR restriction fragment length polymorphism markers in selection programs for sexual precocity in beef heifers. Nevertheless, these markers make possible the genotype characterization and may be used in additional studies to evaluate the genetic structure in other bovine populations.


Subject(s)
Animals , Male , Female , Cattle/genetics , Crosses, Genetic , Polymorphism, Genetic , Receptors, FSH/genetics , Receptors, LH/genetics , Genotype , Meat , Polymerase Chain Reaction , Reproduction/genetics
4.
Arq. bras. endocrinol. metab ; 51(6): 920-929, ago. 2007. tab
Article in Portuguese | LILACS | ID: lil-464283

ABSTRACT

A falência ovariana prematura (FOP) acomete aproximadamente 1:1000 mulheres antes dos 30 anos, 1:250 em torno dos 35 anos e de 1:100 aos 40 anos. Manifesta-se como amenorréia primária ou amenorréia secundária, não podendo ser considerada definitiva em todas as pacientes, uma vez que a concepção espontânea pode ocorrer em até 5-10 por cento das FOP. Na maioria dos casos apresenta-se na forma esporádica, pois apenas 5 por cento apresentam história familial. Entre as causas conhecidas estão as alterações cromossômicas, dos genes ligados ao cromossomo X e cromossomos autossômicos, doenças autoimunes, alterações tóxicas e iatrogênicas. Com relativa freqüência, a causa etiológica não é obtida, sendo então denominada de idiopática. O diagnóstico da FOP é feito baseado na história clínica e níveis elevados do hormônio folículo estimulante (FSH), sendo posteriormente investigadas as causas mais específicas. O manejo clínico visa o suporte emocional, o tratamento hormonal com estrogênios e progestogênios, a abordagem da infertilidade e a prevenção de co-morbidades como a osteoporose e potencial maior risco cardiovascular.


Premature ovarian failure occurs in approximately 1:1000 women before 30 years, 1:250 by 35 years and 1:100 by the age of 40. It is characterized by primary or secondary amenorrhea and cannot be considered as definitive because spontaneous conception may occur in 5 to 10 percent of cases. In 95 percent of cases, premature ovarian failure is sporadic. The known causes of premature ovarian failure include chromosomal defects, autoimmune diseases, exposure to radiation or chemotherapy, surgical procedures, and certain drugs. Frequently, however, the etiology is not clear and these cases are considered to be idiopathic. Premature ovarian failure is defined by gonadal failure and high serum follicle-stimulating hormone (FSH) levels. Clinical approach includes emotional support, hormonal therapy with estrogens and progesterone or progestogens, infertility treatment, and prevention of osteoporosis and potential cardiovascular risk.


Subject(s)
Adult , Female , Humans , Autoimmune Diseases/complications , Follicular Atresia/genetics , Primary Ovarian Insufficiency/etiology , Amenorrhea/etiology , Biomarkers/blood , Estrogen Replacement Therapy , Estrogens/therapeutic use , Follicle Stimulating Hormone/blood , Hypogonadism/etiology , Infertility, Female/etiology , Mutation/genetics , Primary Ovarian Insufficiency/genetics , Primary Ovarian Insufficiency/therapy , Ovarian Follicle/abnormalities , Progesterone/therapeutic use , Progestins/therapeutic use , Receptors, FSH/genetics
5.
Indian J Exp Biol ; 2005 Nov; 43(11): 993-1000
Article in English | IMSEAR | ID: sea-60465

ABSTRACT

The role of follicle stimulating harmone(FSH) in male reproductive function remains a matter of debate although recent evidences strongly suggest a role despite the controversies that arose following the results obtained with FSH-beta null mice and observations from human FSH receptor mutations. This review summarizes the recent developments of our understanding on the role of FSH in male reproduction. Specifically the results obtained with FSH-beta and FORKO null mice are be discussed in light of our observations employing active and passive neutralization of endogenous FSH in rodents and primates along with other studies. On the basis of results obtained employing a variety of models it can be conclude unequivocally that FSH regulates Leydig cell function and is essential for normal quantitative spermatogenesis.


Subject(s)
Animals , Follicle Stimulating Hormone/metabolism , Humans , Leydig Cells/metabolism , Male , Mice , Mice, Knockout , Mutation , Receptors, FSH/genetics , Spermatogenesis , Testosterone/metabolism
6.
Genet. mol. res. (Online) ; 4(3): 496-505, 2005. tab
Article in English | LILACS | ID: lil-444962

ABSTRACT

A population of 370 European-Zebu composite beef heifers, consisting of six different breed compositions (A-F), were characterized genetically, using RFLP markers of luteinizing hormone receptor (LHR) and follicle-stimulating hormone receptor (FSHR) genes. Our objectives were to genetically characterize this population and to determine the structure and the genetic variability of this hybrid herd. The genotypes were determined through PCR, followed by digestion with restriction endonucleases. The PCR-RFLP analysis made it possible to identify the LHR and FSHR genotypes, as well as to characterize the degree of heterozygosis, which was high for all of the breed compositions, for both loci, except for two combinations for LHR (B and C). The observed heterozygosity (Ho) was lower than the expected heterozygosity (He) for compositions C (for LHR) and A and D (for FSHR); however, for the population as a whole, Ho was above He (with a mean of 57 versus 46%, respectively), reflecting the elevated genetic variability in this population and also the informative value of the RFLP markers, which could be useful for population genetic characterization studies. The analysis of the degree of genetic structure of this population, estimated by the Nei's statistic, for both loci, indicated an elevated total genetic diversity (HT = 47%), with most of this variability being due to intrapopulational diversity (HS = 46%), with a low degree of genetic differentiation among the six breed compositions (GST = 1.2%). The estimates generated by the Wright's F statistic indicated a non-endogamic population, with excess heterozygotes (FIT = -0.22), which was also observed at the intrapopulational level (FIS = -0.23). The results gave evidence that the genetic selection applied to this European-Zebu composite population did not affect the expected high genetic variability for this type of crossbreeding, which makes it possible to use these animals to obtain economically valuable productiv...


Subject(s)
Animals , Female , Genetic Variation , Cattle/genetics , Receptors, FSH/genetics , Receptors, LH/genetics , Alleles , Genetic Carrier Screening , Genotype , Genetic Markers/genetics , Polymorphism, Restriction Fragment Length , Polymerase Chain Reaction
SELECTION OF CITATIONS
SEARCH DETAIL